Patients do not necessarily have to take Entecavir for the rest of their lives, it needs to be judged according to the actual condition of the patient. Entecavir is an antiviral drug for chronic hepatitis B with active viral replication and persistently elevated serum alanine aminotransferase. If liver function returns to normal after treatment with entecavir, the drug can be discontinued as prescribed by the doctor, and there is no need to use the drug for the rest of one’s life. However, for those whose hepatitis B has progressed to cirrhosis or liver cancer, they need to take entecavir treatment for the rest of their lives. Some patients may experience adverse reactions such as headache, fatigue, dizziness, and nausea after using the drug. The drug is contraindicated if you are allergic to entecavir or the components of the drug. For some patients with renal insufficiency and liver transplant recipients, it is necessary to follow the doctor’s instructions to adjust entecavir, monitor liver and kidney functions during the use of the drug. Patients are advised to use Entecavir under the supervision of a doctor, and to inform the doctor promptly if they experience any discomfort while using the drug. Patients should also take appropriate protective measures to avoid transmission of the virus to other healthy people.